Breaking News

ACM Global Central Lab Appoints Logistics Director

May 20, 2014

Cunningham brings manufacturing, logistics and supply chain expertise

Richard Cunningham has been appointed director of Global Logistics at ACM Global Central Laboratory. Mr. Cunningham will be responsible for the ongoing development and implementation of ACM’s strategy, processes and network of partner service providers for the management of global logistics supporting clinical trials.
Mr. Cunningham joins the company from Globex24 CLM Ltd., where he served as the regional manager responsible for operations and development of logistics for the UK and Ireland. Previously he served as director of ADX Global Ltd. Mr. Cunningham has more than 20 years of experience having held various manufacturing, logistics and supply chain management roles at TCM International Ltd, Korean Air Cargo, and Bax Global.
“Richard is highly knowledgeable in all aspects of logistics, including operations, couriers, regulations, chain of custody elements, and network management,” said Jerry Boxall, managing director, ACM Europe and Asia. “His extensive knowledge of the biopharma industry will be a significant asset as we expand our global network of ACM Global laboratories, with ACM Singapore and ACM Shanghai in the Asia-Pacific region being our most recent area for expansion.”

Related Packaging:

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research